Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications BioLineRx Ltd. Nasdaq

Equities

BLRX

US09071M2052

Market Closed - Nasdaq
Other stock markets
 21:00:00 31/05/2024 BST 		5-day change 1st Jan Change
0.7456 USD -9.05% Intraday chart for BioLineRx Ltd. +8.85% -52.51%
05-30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
05-28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. BLRX Stock
  5. News BioLineRx Ltd.
  6. Official Publications